169 related articles for article (PubMed ID: 24438193)
1. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.
Liang L; Nong L; Zhang S; Zhao J; Ti H; Dong Y; Zhang B; Li T
J Exp Clin Cancer Res; 2014 Jan; 33(1):7. PubMed ID: 24438193
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
[TBL] [Abstract][Full Text] [Related]
3. The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.
Liang L; Zhang Z; Wang Y; Nong L; Zheng Y; Qu L; Zhang B; Li T
Biomed Res Int; 2015; 2015():435423. PubMed ID: 26221594
[TBL] [Abstract][Full Text] [Related]
4. [Expression of microRNA in extranodal NK/T cell lymphoma, nasal type].
Ti HJ; Nong L; Wang W; Zhang S; Li T
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):610-5. PubMed ID: 22177245
[TBL] [Abstract][Full Text] [Related]
5. [PRDM1 expression and its relationship with PI3K/AKT pathway activation in extranodal NK/T cell lymphoma-nasal type].
Liu JM; Liang L; Huang SS; Li T
Zhonghua Xue Ye Xue Za Zhi; 2018 Dec; 39(12):1010-1016. PubMed ID: 30612403
[No Abstract] [Full Text] [Related]
6. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas.
Nie K; Gomez M; Landgraf P; Garcia JF; Liu Y; Tan LH; Chadburn A; Tuschl T; Knowles DM; Tam W
Am J Pathol; 2008 Jul; 173(1):242-52. PubMed ID: 18583325
[TBL] [Abstract][Full Text] [Related]
7. Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.
Baytak E; Gong Q; Akman B; Yuan H; Chan WC; Küçük C
Tumour Biol; 2017 May; 39(5):1010428317701648. PubMed ID: 28468592
[TBL] [Abstract][Full Text] [Related]
8. [Expression of natural killer cell development-associated transcription factors in nasal NK/T-cell lymphomas occurring in Chinese population].
Zhang S; Nong L; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):366-71. PubMed ID: 21055151
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing.
Motsch N; Alles J; Imig J; Zhu J; Barth S; Reineke T; Tinguely M; Cogliatti S; Dueck A; Meister G; Renner C; Grässer FA
PLoS One; 2012; 7(8):e42193. PubMed ID: 22870299
[TBL] [Abstract][Full Text] [Related]
10. [Study on expression of natural killer (NK) cell C-type lectin-like receptors in nasal NK/T-cell lymphomas].
Nong L; Zhang S; Li Y; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):319-24. PubMed ID: 20654155
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.
Komabayashi Y; Kishibe K; Nagato T; Ueda S; Takahara M; Harabuchi Y
Am J Hematol; 2014 Jan; 89(1):25-33. PubMed ID: 23963825
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Guo WW; Chen LH; Yin W; Mo LX
Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
[TBL] [Abstract][Full Text] [Related]
13. [Extranodal nasal type NK/T-cell lymphoma: clinicopathologic and prognostic study of 55 cases].
Li L; Liu YH; Zhuang HG; Luo XL; Zhang F; Xu FP; Luo DL
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):237-42. PubMed ID: 19575894
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
15. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
[TBL] [Abstract][Full Text] [Related]
16. ATP-binding cassette sub-family C member 4 (ABCC4) is overexpressed in human NK/T-cell lymphoma and regulates chemotherapy sensitivity: Potential as a functional therapeutic target.
Zhang X; Zhao L; Li X; Wang X; Li L; Fu X; Sun Z; Li Z; Nan F; Chang Y; Zhang M
Leuk Res; 2015 Dec; 39(12):1448-54. PubMed ID: 26499190
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-150 enhances radiosensitivity by inhibiting the AKT pathway in NK/T cell lymphoma.
Wu SJ; Chen J; Wu B; Wang YJ; Guo KY
J Exp Clin Cancer Res; 2018 Jan; 37(1):18. PubMed ID: 29386059
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-146a downregulates NFκB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma.
Paik JH; Jang JY; Jeon YK; Kim WY; Kim TM; Heo DS; Kim CW
Clin Cancer Res; 2011 Jul; 17(14):4761-71. PubMed ID: 21610143
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7.
Nie K; Zhang T; Allawi H; Gomez M; Liu Y; Chadburn A; Wang YL; Knowles DM; Tam W
Am J Pathol; 2010 Sep; 177(3):1470-9. PubMed ID: 20651244
[TBL] [Abstract][Full Text] [Related]
20. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
